gabapentin

Generic: gabapentin

Labeler: strides pharma science limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler strides pharma science limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

gabapentin 600 mg/1

Manufacturer
Strides Pharma Science Limited

Identifiers & Regulatory

Product NDC 64380-727
Product ID 64380-727_a4928566-6bc9-4a2a-a368-c68afc402368
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203244
Listing Expiration 2026-12-31
Marketing Start 2025-11-10

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 64380727
Hyphenated Format 64380-727

Supplemental Identifiers

RxCUI
310433 310434
UPC
0364380728016 0364380727019
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA203244 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 600 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 CONTAINER (64380-727-01)
  • 500 TABLET in 1 CONTAINER (64380-727-02)
source: ndc

Packages (2)

64380-727-01 100 TABLET in 1 CONTAINER (64380-727-01) 64380-727-02 500 TABLET in 1 CONTAINER (64380-727-02)

Ingredients (1)

gabapentin (600 mg/1)

Linked Drug Pages (1)

Gabapentin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a4928566-6bc9-4a2a-a368-c68afc402368", "openfda": {"nui": ["N0000008486"], "upc": ["0364380728016", "0364380727019"], "unii": ["6CW7F3G59X"], "rxcui": ["310433", "310434"], "spl_set_id": ["bec31452-b52b-4698-ba4c-0b614780ee84"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Strides Pharma Science Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 CONTAINER (64380-727-01)", "package_ndc": "64380-727-01", "marketing_start_date": "20251110"}, {"sample": false, "description": "500 TABLET in 1 CONTAINER (64380-727-02)", "package_ndc": "64380-727-02", "marketing_start_date": "20251110"}], "brand_name": "Gabapentin", "product_id": "64380-727_a4928566-6bc9-4a2a-a368-c68afc402368", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "64380-727", "generic_name": "Gabapentin", "labeler_name": "Strides Pharma Science Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "600 mg/1"}], "application_number": "ANDA203244", "marketing_category": "ANDA", "marketing_start_date": "20251110", "listing_expiration_date": "20261231"}